Vascular Solutions (VASC) '3-for-3' in 2015; Canaccord Genuity Reiterates Buy

October 21, 2015 11:07 AM

Canaccord Genuity reiterated a Buy rating and $41.50 price target on Vascular Solutions (NASDAQ: VASC), following the company's 3Q15 earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found